Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects
Clinical trial NCT02585804 · COMPLETED
Trial details
- NCT number
- NCT02585804
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-04-24
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.